ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.

Zhejiang Garden Biopharmaceutical Co.,Ltd.

300401

CNE100001XX7

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
12.36 ^CNY	+0.16%		-6.36%	+4.66%

04-15	Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-20	Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Zhejiang Garden Biopharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.

August 22, 2023 at 12:20 pm

Zhejiang Garden Biopharmaceutical Co.,Ltd. (SZSE:300401) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of its shares. The program will be valid till 6 months.

Latest news about Zhejiang Garden Biopharmaceutical Co.,Ltd.

Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-15	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.	03-07	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback announced on September 14, 2023, has completed with 9,307,200 shares, representing 1.7% for CNY 100 million.	03-05	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Announces Board Appointments	02-23	CI
Zhejiang Garden Biopharmaceutical's Unit Gets Nod for Eight New Products	02-05	MT
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.	01-03	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	20/10/23	CI
Tranche Update on Zhejiang Garden Biopharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 14, 2023.	11/10/23	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on September 7, 2023.	14/09/23	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	22/08/23	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. authorizes a Buyback Plan.	21/08/23	CI
Zhejiang Garden Biopharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	07/08/23	CI
Zhejiang Garden Biopharma Registers Acid Reflux Drug	04/08/23	MT
Zhejiang Garden Bio-chemical High-tech Co., Ltd. has Changed its Name to Zhejiang Garden Biopharmaceutical Co., Ltd	28/04/23	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. announced a financing transaction	13/02/23	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	21/10/22	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	15/08/22	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	20/04/22	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	29/03/22	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. agreed to acquire Zhejiang Garden Pharmaceutical Co., Ltd. for CNY 1.1 billion.	27/10/21	CI
Zhejiang Garden Bio-chemical High-tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/10/21	CI
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	30/07/21	CI
Zhejiang Garden Bio-Chemical High-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	16/04/21	CI

Chart Zhejiang Garden Biopharmaceutical Co.,Ltd.

Duration

Period

Chart Zhejiang Garden Biopharmaceutical Co.,Ltd.

More charts

Company Profile

Zhejiang Garden Biopharmaceutical Co Ltd, formerly Zhejiang Garden Bio-chemical High-tech Co Ltd, is a China-based company mainly engaged in the research, development, production and sales of vitamin D3 upstream and downstream products. The Company's vitamin products mainly include lanolin cholesterol, food and pharmaceutical grade vitamin D3, 25-hydroxyvitamin D3 and others. The Company also focuses on the research and development, production and sales of high-tech barrier preparations in the fields of cardiovascular, nervous system and other chronic diseases. The other products of the Company include Levofloxacin Tablets, Doxofylline Injection, Lipoic Acid Injection, Escitalopram Oxalate Tablets and others.

Sector

Pharmaceuticals

Calendar

16/05/2024 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ZHEJIANG GARDEN BIOPHARMACEUTICAL CO.,LTD.	+4.66%	911M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.11%	44.4B
OTSUKA HOLDINGS CO., LTD.	+24.60%	23.03B
SANDOZ GROUP AG	+17.22%	15.14B
CIPLA LIMITED	+13.02%	13.12B
ZYDUS LIFESCIENCES LIMITED	+44.62%	11.85B
ONO PHARMACEUTICAL CO., LTD.	-8.33%	6.99B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.22%	5.52B

Generic Pharmaceuticals